greeksoup/ stocks
Stocks / United States / IDXX / Q4 FY2024

IDEXX Laboratories Inc. Q4 FY2024 results: revenue $954 million, up 5.8% on the year

IDEXX Laboratories Inc. (IDXX) reported revenue of $954 million for Q4 FY2024, the quarter ended 31 December 2024, up 5.8% on the same quarter a year earlier. Net income was $216 million, up 11.1% on the year, and diluted earnings per share $2.62. The figures are the company's own, from the 10-K it filed with the SEC on 21 February 2025.

Revenue$954 millionup 5.8%
Net income$216 millionup 11.1%
Diluted EPS$2.62
QuarterQ4 FY2024ended 31 December 2024

The quarter, against the one before and a year earlier

LineQ4 FY2024Q3 FY2024Q4 FY2023Change on the year
Revenue954976902+5.8%
Cost of revenue384380375+2.2%
Gross profit571596526+8.5%
Gross margin59.8%61.1%58.4%
Research and development57.754.051.8+11.4%
Operating income262304245+6.7%
Operating margin27.4%31.2%27.2%
Interest expense7.57.79.3-19.1%
Pre-tax income256299240+7.0%
Income tax40.266.145.1-10.9%
Effective tax rate15.7%22.1%18.8%
Net income216233195+11.1%
Net margin22.7%23.9%21.6%
Diluted EPS$2.62$2.80$2.31+13.4%

$ million except per share. Fourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

LineQ4 FY2024Q3 FY2024Q4 FY2023Change on the year
Operating cash flow262220250+4.9%
Capital expenditure29.328.132.6-10.1%
Free cash flow233192217+7.1%
Free cash flow margin24.4%19.7%24.1%
Depreciation and amortisation33.734.129.7+13.3%
Share-based compensation14.315.915.2-6.0%
Buybacks24622136.9+567.5%
Diluted shares, weighted83m83m84m-0.9%
Shares outstanding at period end82m82m83m-1.7%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ4 FY2024Q3 FY2024Q4 FY2023Change on the year
Total assets3,2933,3513,260+1.0%
Cash and equivalents288309454-36.5%
Receivables474511457+3.5%
Inventory382390380+0.4%
Goodwill405412366+10.7%
Long-term debt618525698-11.5%
Operating lease liabilities97.810399.7-1.8%
Shareholders' equity1,5951,6181,485+7.5%

Quarterly results, the last 12 quarters

Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026
Revenue9169029641,0049769549981,1091,1051,0911,1411,217
Cost of revenue368375371384380384375415422432418437
Gross profit548526593619596571623695683658723779
Gross margin60%58%62%62%61%60%62%63%62%60%63%64%
R&D48.051.852.655.554.057.759.161.963.466.865.865.4
Operating income275245299264304262317373355316363426
Operating margin30%27%31%26%31%27%32%34%32%29%32%35%
Interest expense8.69.37.98.17.77.57.711.310.79.27.710.2
Pre-tax income268240295259299256310362345307355417
Tax rate21%19%20%22%22%16%22%19%20%19%22%19%
Net income212195236203233216243294275248278338
Net margin23%22%24%20%24%23%24%26%25%23%24%28%
Diluted EPS$2.53$2.31$2.81$2.44$2.80$2.62$2.96$3.63$3.40$3.09$3.47$4.27
Operating cash flow272250199248220262238186402356266347
Capital expenditure34.132.630.333.328.129.330.034.131.129.432.024.6
Free cash flow238217168215192233208152371326234323
Buybacks35.136.9155216221246401338240238351347
Shares outstanding83m83m83m82m82m82m81m80m80m80m79m79m
Filing10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q

* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Source

10-K for the period ended 31 December 2024, filed 21 February 2025, accession 0000874716-25-000037: the filing on EDGAR. All of IDEXX Laboratories Inc.'s filings: EDGAR company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install